Functional neuroimaging in schizophrenia: diagnosis and drug discovery

Trends in Pharmacological Sciences
Philip K McGuirePaolo Fusar-Poli

Abstract

Functional neuroimaging provides a direct way of investigating the pathophysiology of schizophrenia in vivo. The function of neurotransmitters implicated in schizophrenia, such as dopamine and glutamate, can be assessed using molecular imaging techniques such as positron emission tomography (PET), single-photon emission tomography (SPET) and magnetic resonance spectroscopy (MRS). Regional brain activity, particularly that associated with the cognitive processes and symptoms associated with the disorder, can be studied using functional magnetic resonance imaging (fMRI). Here, we focus on the potential for the use of these techniques in the diagnosis of schizophrenia and in the development of new drugs for its treatment.

References

Nov 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·P SeemanK Wong
Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·P F LiddleR S Frackowiak
Dec 1, 1995·Archives of General Psychiatry·J W Olney, N B Farber
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·A BreierD Pickar
Jun 5, 1998·Trends in Pharmacological Sciences·M S LidowP S Goldman-Rakic
Aug 28, 1998·Schizophrenia Research·K K Zakzanis, K T Hansen
Nov 11, 1998·Nature Medicine·A D Lopez, C C Murray
Jan 14, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J W NewcomerJ W Olney
Feb 2, 1999·The British Journal of Psychiatry : the Journal of Mental Science·P K McGuireP F Liddle
Feb 16, 1999·Schizophrenia Research·J HietalaR K Salokangas
Aug 31, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·C H Fu, P K McGuire
Nov 14, 2000·Archives of General Psychiatry·S S ShergillP K McGuire
Apr 6, 2001·Clinical Neuropharmacology·S I DeutschJ Mastropaolo
Feb 28, 2002·Nature Neuroscience·Andreas Meyer-LindenbergKaren Faith Berman
Aug 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·J M S Pearce
Dec 31, 2002·The American Journal of Psychiatry·Thomas J RaedlerDaniel R Weinberger
Jun 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thomas J RaedlerDaniel R Weinberger
Oct 2, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Adrienne C LahtiCarol A Tamminga
Oct 29, 2003·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Anissa Abi-Dargham, Holly Moore
Oct 30, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·José Alexandre de Souza CrippaGeraldo Filho Busatto
Jun 1, 2004·The American Journal of Psychiatry·Herbert Y MeltzerUNKNOWN Meta-Trial Study Group
Nov 25, 2004·Schizophrenia Research·Harri J TuominenKristian Wahlbeck
Jan 29, 2005·The American Journal of Psychiatry·Laura M RowlandWilliam M Brooks
Feb 8, 2005·Schizophrenia Research·Matthew M Kurtz
Feb 19, 2005·Psychopharmacology·James M StoneLyn S Pilowsky
Mar 9, 2005·Archives of General Psychiatry·Rajendra A MoreyAysenil Belger
May 3, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Nick Craddock, Michael J Owen
May 24, 2005·NeuroImage·Stephen LaConteXiaoping Hu
Jun 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Joseph H CallicottDaniel R Weinberger

❮ Previous
Next ❯

Citations

Mar 24, 2010·Radiology·Nivedita AgarwalPerry F Renshaw
Jan 30, 2014·Annual Review of Clinical Psychology·P Fusar-PoliT H McGlashan
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Akiko Hayashi-TakagiAkira Sawa
May 9, 2014·Neurotoxicity Research·Trevor ArcherMax Rapp Ricciardi
Jul 17, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Joseph KambeitzOliver D Howes
Mar 1, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Michael BodnarMartin Lepage
Mar 28, 2009·Schizophrenia Bulletin·Oliver D Howes, Shitij Kapur
Jul 30, 2009·Neuropsychology Review·Barton W PalmerRobert K Heaton
Jan 29, 2013·European Archives of Psychiatry and Clinical Neuroscience·Yojiro UmezakiAkira Toyofuku
Jan 19, 2011·Imaging in Medicine·Judy L ThompsonAnissa Abi-Dargham
Apr 3, 2013·European Journal of Clinical Pharmacology·Melvin GeorgeSteven Aibor Dkhar
Nov 15, 2011·Schizophrenia Bulletin·Paolo Fusar-PoliStefan Borgwardt
Jan 28, 2012·Schizophrenia Bulletin·Paolo Fusar-Poli, Andreas Meyer-Lindenberg
Jan 28, 2012·Schizophrenia Bulletin·Paolo Fusar-Poli, Andreas Meyer-Lindenberg
Feb 26, 2016·Translational Psychiatry·J M StevensonJ R Bishop
Sep 21, 2011·Psychoneuroendocrinology·Martino Belvederi MurriValeria Mondelli
Feb 11, 2010·Neuroscience and Biobehavioral Reviews·R SmieskovaS J Borgwardt
Dec 22, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Euitae KimJun Soo Kwon
Apr 28, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Euitae KimJun Soo Kwon
Oct 7, 2008·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Oliver D HowesShitij Kapur
May 8, 2009·Chembiochem : a European Journal of Chemical Biology·Pedro Rosa-NetoEsther Schirrmacher
Oct 10, 2013·Psychiatry and Clinical Neurosciences·Shin OginoNoboru Yamaguchi
May 28, 2014·Early Intervention in Psychiatry·Monika SchlögelhoferNilufar Mossaheb
Sep 4, 2012·European Archives of Psychiatry and Clinical Neuroscience·C Christoph SchultzRalf G M Schlösser
Dec 10, 2013·Lancet·Oliver D Howes, Robin M Murray
Jan 31, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·P Fusar-PoliS Borgwardt
Nov 10, 2012·European Psychiatry : the Journal of the Association of European Psychiatrists·P Fusar-PoliP K McGuire
Apr 14, 2015·Schizophrenia Research·Da-Jung ShinJun Soo Kwon
Sep 16, 2008·The International Journal of Neuropsychopharmacology·Daniela ViganoDaniela Parolaro
Oct 18, 2008·The International Journal of Neuropsychopharmacology·Paolo Fusar-PoliPhilip McGuire
Aug 13, 2013·PloS One·Sean P DavidJohn P A Ioannidis
Jan 15, 2015·Journal of Psychopharmacology·Oliver HowesJames Stone
Dec 2, 2008·Biological & Pharmaceutical Bulletin·Kerstin SanderHolger Stark

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Related Papers

European Psychiatry : the Journal of the Association of European Psychiatrists
Paolo Fusar-PoliPhilip K McGuire
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Paolo Fusar-PoliPhilip K McGuire
Neuroscience and Biobehavioral Reviews
Paolo Fusar-PoliE Sacchetti
© 2021 Meta ULC. All rights reserved